169 related articles for article (PubMed ID: 22615840)
1. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression.
Li Z; Qu L; Dong Q; Huang B; Li H; Tang Z; Xu Y; Luo W; Liu L; Qiu X; Wang E
PLoS One; 2012; 7(5):e36903. PubMed ID: 22615840
[TBL] [Abstract][Full Text] [Related]
2. CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.
Chang YW; Chiu CF; Lee KY; Hong CC; Wang YY; Cheng CC; Jan YH; Huang MS; Hsiao M; Ma JT; Su JL
Am J Respir Crit Care Med; 2015 Jul; 192(1):64-75. PubMed ID: 25906011
[TBL] [Abstract][Full Text] [Related]
3. CARMA3 regulates the invasion, migration, and apoptosis of non-small cell lung cancer cells by activating NF-кB and suppressing the P38 MAPK signaling pathway.
Xia ZX; Li ZX; Zhang M; Sun LM; Zhang QF; Qiu XS
Exp Mol Pathol; 2016 Apr; 100(2):353-60. PubMed ID: 26526492
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
6. CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression.
Miao Z; Zhao T; Wang Z; Xu Y; Song Y; Wu J; Xu H
Biochem Biophys Res Commun; 2012 Sep; 425(4):781-7. PubMed ID: 22884800
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
8. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
9. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
Chen C; Peng S; Li P; Ma L; Gan X
Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion.
Whitsett TG; Cheng E; Inge L; Asrani K; Jameson NM; Hostetter G; Weiss GJ; Kingsley CB; Loftus JC; Bremner R; Tran NL; Winkles JA
Am J Pathol; 2012 Jul; 181(1):111-20. PubMed ID: 22634180
[TBL] [Abstract][Full Text] [Related]
11. Circulating Proteoglycan Endocan Mediates EGFR-Driven Progression of Non-Small Cell Lung Cancer.
Yang YC; Pan KF; Lee WJ; Chang JH; Tan P; Gu CC; Chang WM; Yang SF; Hsiao M; Hua KT; Chien MH
Cancer Res; 2020 Aug; 80(16):3292-3304. PubMed ID: 32561533
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues.
Liang H; Zhang J; Shao C; Zhao L; Xu W; Sutherland LC; Wang K
J Exp Clin Cancer Res; 2012 Apr; 31(1):36. PubMed ID: 22537942
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
Li X; Zhang Q; Fan K; Li B; Li H; Qi H; Guo J; Cao Y; Sun H
Int J Mol Sci; 2016 Mar; 17(4):437. PubMed ID: 27023518
[TBL] [Abstract][Full Text] [Related]
14. CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.
Du S; Jia L; Zhang Y; Fang L; Zhang X; Fan Y
Tumour Biol; 2014 Jun; 35(6):5965-70. PubMed ID: 24633921
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
Sunaga N; Imai H; Shimizu K; Shames DS; Kakegawa S; Girard L; Sato M; Kaira K; Ishizuka T; Gazdar AF; Minna JD; Mori M
Int J Cancer; 2012 Apr; 130(8):1733-44. PubMed ID: 21544811
[TBL] [Abstract][Full Text] [Related]
16. CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion.
Shi D; Zhang Z; Kong C
Technol Cancer Res Treat; 2021; 20():15330338211027915. PubMed ID: 34190011
[TBL] [Abstract][Full Text] [Related]
17. CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells.
Zhao T; Miao Z; Wang Z; Xu Y; Wu J; Liu X; You Y; Li J
Tumour Biol; 2013 Oct; 34(5):3041-7. PubMed ID: 23708960
[TBL] [Abstract][Full Text] [Related]
18. βKlotho is identified as a target for theranostics in non-small cell lung cancer.
Li F; Li X; Li Z; Ji W; Lu S; Xia W
Theranostics; 2019; 9(25):7474-7489. PubMed ID: 31695781
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
Cragg MS; Kuroda J; Puthalakath H; Huang DC; Strasser A
PLoS Med; 2007 Oct; 4(10):1681-89; discussion 1690. PubMed ID: 17973573
[TBL] [Abstract][Full Text] [Related]
20. SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling.
Dasgupta S; Jang JS; Shao C; Mukhopadhyay ND; Sokhi UK; Das SK; Brait M; Talbot C; Yung RC; Begum S; Westra WH; Hoque MO; Yang P; Yi JE; Lam S; Gazdar AF; Fisher PB; Jen J; Sidransky D
J Mol Med (Berl); 2013 Mar; 91(3):381-93. PubMed ID: 22968441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
